ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1152

“Doctor, a Storm Is Coming and My Joints Hurt”: Evaluating Associations between Weather Changes and Arthritis Symptoms

Jeffrey R. Curtis1, Shuo Yang1, Cassie Clinton1, Lang Chen1, W. Benjamin Nowell2, Huifeng Yun1 and David Curtis3, 1University of Alabama at Birmingham, Birmingham, AL, 2Global Healthy Living Foundation, Upper Nyack, NY, 3Global Healthy Living Foundation, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, pain and registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Arthritis symptoms reported by patients have been anecdotally associated with weather changes, but large-scale, systemic evaluations are few in number. A variety of parameters associated with weather that might underlie arthritis-related pain and related symptoms have been inconsistently reported.

Methods: Patients participating in the ArthritisPower registry and contributing data via a Smartphone or computer App from the continental U.S. were eligible for analysis. Geolocation (latitude/longitude) was extracted from the Smartphone’s physical location or computer IP address. Various weather parameters (e.g. temperature, humidity, wind speed/direction, barometric pressure) were obtained from the nearest National Oceanic and Atmospheric Administration (NOAA) weather station based on patient’s geolocation. Various restrictions in the maximal allowable distance to the nearest weather station (e.g. <25 miles) were evaluated. Patient disease activity by the RAPID3, and patient reported outcomes (PROs) including pain interference, fatigue and physical function measured by the NIH PROMIS instruments (using computer adaptive testing) were obtained from the registry, and associated with NOAA weather data at that same time (to the nearest hour) and location, and at the same location 24 hours before and after each patient observation. Cross-sectional correlation between various weather parameters and PROs were quantified as r values using Pearson correlation coefficients. A “cold front” definition was proposed based on the confluence of longitudinal change over 3 days in relative humidity, wind direction, barometric pressure, and dew point.

Results: At the time of this analysis, 1334 unique patients contributed 2425 PRO observations with linkable NOAA weather data. Mean(SD) age was 53.9(10.3) years, 91% women, 90% white. In terms of various arthritis conditions represented in ArthritisPower, 45% had rheumatoid arthritis, 10% psoriatic arthritis, 9% ankylosing spondylitis, and 62% osteoarthritis (with or without a concomitant inflammatory arthritis). Many of the correlations between various weather parameters and PROs were statistically significant (p < 0.001) albeit numerically weak (all r values < 0.2). For patients contributing any PRO data at the time of an evolving cold front using the proposed definition, patient symptoms were not different as measured by various PROs (Table). 

Conclusion: Weather is quantitatively related to patient’s arthritis symptoms. Additional work is ongoing to refine specific weather parameters and their associations with PROs in order to provide potentially actionable information to patients and their healthcare providers.

Table: Association between Patient Symptoms and the Presence of a Cold Front based on Geolocation and Linked Weather Data (n=2425)

 

Cold Front

No Cold Front

RAPID3 (0-30)

15.0 (9.0, 20.0)

17.0 (13.0, 21.0)

PROMIS Pain Interference (1-100)

63 (55, 67)

66 (62, 70)

PROMIS Fatigue (1-100)

60 (51, 64)

64 (59, 71)

PROMIS Physical Function (1-100)

63 (55, 67)

66 (62, 70)

 


Disclosure: J. R. Curtis, AbbVie, Amgen, BMS, Eli Lilly and Company, Janssen, Pfizer, Roche/Genentech, Corrona, UCB, Myriad, 2, 5; S. Yang, None; C. Clinton, None; L. Chen, None; W. B. Nowell, GlaxoSmithKline, 1,Merck & Co., 1,Pfizer, Inc., 1, 2,AbbVie Inc., 1,Bristol-Myers Squibb, 1, 2,Eli Lilly and Co., 1, 2,Janssen, 1,Novartis, 2; H. Yun, Pfizer, Bristol-Myers Squibb, 2; D. Curtis, None.

To cite this abstract in AMA style:

Curtis JR, Yang S, Clinton C, Chen L, Nowell WB, Yun H, Curtis D. “Doctor, a Storm Is Coming and My Joints Hurt”: Evaluating Associations between Weather Changes and Arthritis Symptoms [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/doctor-a-storm-is-coming-and-my-joints-hurt-evaluating-associations-between-weather-changes-and-arthritis-symptoms/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/doctor-a-storm-is-coming-and-my-joints-hurt-evaluating-associations-between-weather-changes-and-arthritis-symptoms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology